𝔖 Bobbio Scriptorium

✦ LIBER ✦

TCT-229: First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

Book ID: 119271012
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 110 KB
Volume: 58
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2011.10.234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-242: First Report of A Novel Ablumin

TCT-242: First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

TCT-578 First-in-human Evaluation of a N

TCT-578 First-in-human Evaluation of a Novel Sirolimus-eluting Stent with a Bioabsorbable Polymer for the Treatment of Single, De Novo, Non-complex Coronary Lesions

✍ Erlon de Abreu-Silva; RICARDO COSTA; SAMEER DANI; Mirela Lima; HASIT JOSHI; JAY 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

TCT-267: The PLUS-ONE First-in-Man (FIM)

TCT-267: The PLUS-ONE First-in-Man (FIM) Study: Safety and Efficacy of Low-Dose Paclitaxel and the COBRA-P Drug-Eluting Stent System with a Novel Biodegradable Coating in de novo Coronary Lesions

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 137 KB

TCT-32 First Report of the Four Year Cli

TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

✍ Chevalier, Bernard 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Safety and efficacy of low-dose paclitax

Safety and efficacy of low-dose paclitaxel utilizing the cobra-P drug-eluting stent system with a novel biodegradable coating in de novo coronary lesions: The PLUS-ONE first-in-man study

✍ Calderas, Carlos; Condado, Jose Francisco; Condado, Jose Antonio; Flores, Alejan 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 509 KB